celiac disease
Information
- Disease name
- celiac disease
- Disease ID
- DOID:10608
- Description
- "An autoimmune disease of gastrointestinal tract that is caused by a reaction located_in small intestine to gliadin, a prolamin (gluten protein) found in wheat, and similar proteins found in the crops of the tribe Triticeae. The disease is associated with HLA-DQ gene. It has_symptom abdominal pain, has_symptom constipation, has_symptom diarrhea, has_symptom nausea and vomiting, and has_symptom loss of appetite." [url:http\://en.wikipedia.org/wiki/Coeliac_disease, url:http\://www.celiac.org/, url:http\://www.mayoclinic.com/health/celiac-disease/DS00319, url:http\://www.nlm.nih.gov/medlineplus/ency/article/000233.htm, url:https\://www.niddk.nih.gov/health-information/digestive-diseases/celiac-disease]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05353985 | Active, not recruiting | Phase 2 | A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet | June 30, 2022 | May 6, 2025 |
| NCT04243551 | Active, not recruiting | Phase 2 | Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients | November 1, 2019 | December 2023 |
| NCT05425446 | Active, not recruiting | Phase 1 | Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients | September 19, 2022 | May 31, 2024 |
| NCT04041622 | Active, not recruiting | N/A | Coeliac Disease in the Nord-Trøndelag Health Study (HUNT) | June 17, 2019 | July 2024 |
| NCT05548166 | Active, not recruiting | Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease | October 26, 2020 | December 31, 2026 | |
| NCT03678935 | Active, not recruiting | N/A | Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients | October 1, 2018 | December 31, 2025 |
| NCT04958356 | Active, not recruiting | Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study | November 19, 2018 | December 31, 2032 | |
| NCT04424927 | Active, not recruiting | Phase 2 | PRV-015 in Gluten-free Diet Non-responsive Celiac Disease | August 24, 2020 | August 31, 2024 |
| NCT03439475 | Available | AMG 714 Expanded Access Program | |||
| NCT00620451 | Completed | Phase 2 | Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease | February 2008 | December 2009 |
| NCT00626184 | Completed | Phase 1 | A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease | February 2008 | July 2008 |
| NCT00628823 | Completed | N/A | Treatment of Mild Enteropathy Celiac Disease | March 2003 | December 2008 |
| NCT00639444 | Completed | N/A | Risk of Celiac Disease and Age at Gluten Introduction | September 2004 | November 2013 |
| NCT00669825 | Completed | Phase 1 | Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal | March 2008 | October 2008 |
| NCT00671138 | Completed | Phase 2 | Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity | October 2007 | September 2009 |
| NCT00677495 | Completed | N/A | Gluten-free Diet in Gluten-genetically Predisposed Subjects | May 2007 | June 2020 |
| NCT00782366 | Completed | Predictive Genetic Risk Assessment Trial | March 2008 | January 2010 | |
| NCT00810654 | Completed | Phase 1/Phase 2 | Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease | May 2008 | December 2009 |
| NCT00859391 | Completed | Effects of Gluten Digestion With ALV003 | May 2008 | June 2008 | |
| NCT00879749 | Completed | Phase 1 | Safety Study of Nexvax2 in Subjects With Coeliac Disease | April 2009 | June 2010 |
| NCT00889473 | Completed | Phase 2 | Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease | April 2009 | April 2010 |
| NCT00931892 | Completed | N/A | Serum Markers in Gluten Challenge | April 2009 | August 2011 |
| NCT00959114 | Completed | Phase 2 | Safety and Efficacy of ALV003 for the Treatment of Celiac Disease | August 2009 | October 2010 |
| NCT00962182 | Completed | Phase 1/Phase 2 | Study of Enzyme Supplements to Treat Celiac Disease | August 2008 | December 2017 |
| NCT01045837 | Completed | Phase 2/Phase 3 | Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients | April 2009 | August 2010 |
| NCT01100099 | Completed | Phase 2/Phase 3 | HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease | September 2006 | September 2012 |
| NCT01116505 | Completed | N/A | Treatment of Screen-detected Celiac Disease | August 2008 | August 2012 |
| NCT01129908 | Completed | Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet | May 2010 | July 2012 | |
| NCT01137955 | Completed | N/A | Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease | October 2006 | April 2008 |
| NCT01145287 | Completed | Impact of the Diagnosis of Celiac Disease | February 2007 | April 2016 | |
| NCT01172665 | Completed | Celiac Disease Database | September 2008 | May 5, 2024 | |
| NCT01255696 | Completed | Phase 2 | Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease | November 2010 | June 2011 |
| NCT01257620 | Completed | N/A | Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease | December 2010 | December 2011 |
| NCT01317914 | Completed | N/A | Prospective Study of Undiagnosed Celiac Disease | July 2010 | April 2012 |
| NCT01338324 | Completed | Phase 2/Phase 3 | Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease | April 2010 | September 2011 |
| NCT01396213 | Completed | Phase 2 | A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease | November 7, 2011 | August 20, 2013 |
| NCT01439035 | Completed | N/A | Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults | August 2009 | February 4, 2011 |
| NCT01478867 | Completed | Detection of Immunotoxic Gluten Peptides in Feces | April 2011 | July 2011 | |
| NCT01558557 | Completed | N/A | Gluten Free Diet in People With Schizophrenia: A Pilot Study | June 2008 | January 2014 |
| NCT01558570 | Completed | Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin | July 2011 | February 2012 | |
| NCT01560169 | Completed | Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients | March 2012 | September 2013 | |
| NCT01566110 | Completed | N/A | Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial | March 2012 | March 2018 |
| NCT01574209 | Completed | Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome | April 2012 | October 2012 | |
| NCT01661933 | Completed | Phase 1/Phase 2 | Desensitising Celiac Disease Patients With the Human Hookworm | August 2012 | March 2014 |
| NCT01695681 | Completed | N/A | Screen-detected Coeliac Disease, a Population Based Study | October 1, 2012 | April 15, 2015 |
| NCT01765647 | Completed | Phase 1 | Oral AGY for Celiac Disease | May 2014 | August 2015 |
| NCT01787825 | Completed | N/A | Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease | May 2012 | February 2016 |
| NCT01862510 | Completed | Detection of Celiac Disease in Patients With Hypothyroidism | March 2012 | December 2014 | |
| NCT01893775 | Completed | Phase 1 | Antibody Treatment for Advanced Celiac Disease | June 12, 2013 | December 20, 2019 |
| NCT01909050 | Completed | Immune Response in Celiac Disease on In-vitro Gluten Challenge | February 2013 | March 2018 | |
| NCT05968404 | Completed | A Population-based Study of Celiac Disease in South Europe in Children Between 1 to 5 Years of Age | January 1, 2013 | June 1, 2023 | |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT01932476 | Completed | N/A | Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes | August 2013 | December 2014 |
| NCT05923346 | Completed | N/A | Educational Intervention on Celiac Disease and Gluten-free Diet Through Social Networks (GLUTLEARN Project). | February 1, 2022 | November 1, 2023 |
| NCT01990885 | Completed | Phase 1/Phase 2 | Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. | December 2013 | October 2014 |
| NCT05810441 | Completed | Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis | September 23, 2019 | December 31, 2022 | |
| NCT00138879 | Completed | Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients | May 2003 | June 2005 | |
| NCT02072590 | Completed | Improved Diagnostics of Celiac Disease in Children | August 2011 | November 21, 2023 | |
| NCT02190513 | Completed | Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease | February 2011 | ||
| NCT02220166 | Completed | Phase 2 | Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease | November 2010 | August 2011 |
| NCT02242123 | Completed | Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay. | January 2012 | June 1, 2020 | |
| NCT02244047 | Completed | Phase 1/Phase 2 | Cytokine Profile in Children With Celiac Disease | October 2013 | June 2014 |
| NCT02312349 | Completed | Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City | September 2011 | January 2013 | |
| NCT05733663 | Completed | TCRγδ+ Cells After Gluten-free Diet: A Biomarker for Coeliac Disease? | January 1, 2013 | December 31, 2020 | |
| NCT02344758 | Completed | Early Phase 1 | Gluten-free Diet Monitoring in Urine | April 2013 | December 2013 |
| NCT02451449 | Completed | Celiac Disease and Infertility Among Men and Women in Denmark | January 2015 | November 2018 | |
| NCT02458898 | Completed | N/A | Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease | February 2015 | May 2016 |
| NCT00175760 | Completed | Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease? | December 2004 | October 2006 | |
| NCT05686369 | Completed | A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study) | March 8, 2023 | October 5, 2023 | |
| NCT02472704 | Completed | N/A | Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo | September 2011 | May 2014 |
| NCT00006492 | Completed | Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia | November 2000 | December 2002 | |
| NCT02528799 | Completed | Phase 1 | Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease | August 2015 | January 6, 2017 |
| NCT02551289 | Completed | MAgnetic Resonance Imaging in COeliac Disease | January 2016 | September 30, 2019 | |
| NCT02612766 | Completed | N/A | Safety and Tolerability of Oat Containing Gluten-free Diet | November 2015 | December 2016 |
| NCT02637141 | Completed | Phase 2 | A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease | April 13, 2016 | March 14, 2017 |
| NCT02679014 | Completed | Phase 1 | A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease | March 6, 2016 | August 28, 2016 |
| NCT02690532 | Completed | Gut Permeability Assessment in Celiac and Gluten Sensitive Children | March 2016 | August 1, 2018 | |
| NCT02711397 | Completed | Quantification of Gluten Peptides in Feces | April 2012 | June 2014 | |
| NCT02711696 | Completed | N/A | Randomized Clincal Trial on the Effect of a Restricted Gluten Contamination Elimination Diet Among Celiacs [GluCED] | March 2014 | January 2016 |
| NCT02754609 | Completed | Phase 1 | Hookworm Therapy for Coeliac Disease | September 2016 | October 2019 |
| NCT02805816 | Completed | Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease | June 8, 2016 | July 2018 | |
| NCT04349904 | Completed | Near-Focus NBI Classification of Villous Atrophy in Suspected Coeliac Disease: International Development and Validation | September 6, 2017 | February 3, 2019 | |
| NCT04477239 | Completed | N/A | Diagnostic Performance of Urinary Gluten Immunogenic Peptides in Monitoring the Adherence to Gluten-free Diet. | October 1, 2020 | December 31, 2020 |
| NCT00386165 | Completed | Phase 1 | Safety Study of Larazotide Acetate to Treat Celiac Disease. | November 29, 2005 | January 26, 2006 |
| NCT04524221 | Completed | Phase 1 | PTG-100 for Patients With Celiac Disease | February 26, 2021 | April 3, 2022 |
| NCT00492960 | Completed | Phase 2 | Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease | August 2007 | March 2009 |
| NCT04573959 | Completed | N/A | Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System | October 1, 2015 | June 11, 2020 |
| NCT00540657 | Completed | Phase 2 | A Phase II Study of CCX282-B in Patients With Celiac Disease | October 2007 | July 2008 |
| NCT00555737 | Completed | Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23) | November 2003 | July 2007 | |
| NCT06382506 | Completed | N/A | The Effect of Hazelnut Flour on Blood Glucose | March 21, 2024 | April 21, 2024 |
| NCT03857360 | Completed | N/A | Effectiveness of PENTABIOCEL in Clinical and Laboratory Recovery of Children With Celiac Disease | March 15, 2019 | August 15, 2021 |
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT06402734 | Completed | Effects of Gluten-Free Diet on Nutritional Status in Celiac Patients | October 15, 2018 | March 15, 2020 | |
| NCT04024449 | Completed | Can Celiac Disease Affect Ovarian Function in Adolescent? | January 1, 2017 | May 31, 2018 | |
| NCT04054544 | Completed | Early Phase 1 | Gluten Challenge Study in Celiac Disease Participants (MK-0000-402) | August 28, 2020 | June 23, 2021 |
| NCT04643704 | Completed | Quality of Life and Eating Disorders in Children With FPIES, Food Allergy or Celiac Disease | January 5, 2021 | July 22, 2022 | |
| NCT04604795 | Completed | Phase 1 | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole | November 4, 2020 | June 29, 2021 |
| NCT04239521 | Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata | October 1, 2020 | November 28, 2022 | |
| NCT04240340 | Completed | Experiences of Disclosure in Adolescents With Coeliac Disease | March 1, 2020 | October 17, 2020 | |
| NCT04248855 | Completed | Phase 1 | Assessment of KAN-101 in Celiac Disease (ACeD) | January 21, 2020 | October 8, 2021 |
| NCT00362856 | Completed | Phase 2 | Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects | September 13, 2006 | March 6, 2007 |
| NCT04593251 | Completed | Phase 1 | Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis | September 28, 2020 | April 2, 2024 |
| NCT04351828 | Completed | Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease | November 5, 2018 | April 19, 2019 | |
| NCT02834429 | Completed | Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing | February 2010 | October 2017 | |
| NCT05467865 | Completed | N/A | Celiac Disease: Nutrition Education in Primary School | June 30, 2020 | November 1, 2023 |
| NCT05309330 | Completed | Virtual Celiac Symptoms Study in Adults and Teenagers | August 16, 2022 | March 4, 2023 | |
| NCT03011593 | Completed | N/A | Effect of UGIR in Adults With Compromised Gut Function and Malabsorption | November 2015 | June 2016 |
| NCT03011931 | Completed | Early Phase 1 | Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] | March 2016 | February 2019 |
| NCT03051204 | Completed | OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome | February 28, 2017 | December 11, 2018 | |
| NCT03064997 | Completed | N/A | Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children | January 12, 2016 | June 1, 2016 |
| NCT05227079 | Completed | N/A | Assessing the Histological Quality of Biopsy Samples Obtained With Multibite Forceps | May 1, 2022 | July 30, 2023 |
| NCT03122093 | Completed | Celiac Disease and Diabetes Longitudinal Follow-up and Evaluation Study | May 1, 2017 | January 31, 2021 | |
| NCT03137862 | Completed | N/A | "Gluten Friendly" Treatment in Celiac Disease | March 20, 2017 | January 15, 2018 |
| NCT03143517 | Completed | Fecal Calprotectin Collection Protocol | April 19, 2017 | August 23, 2018 | |
| NCT03152279 | Completed | Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance | December 2016 | November 14, 2018 | |
| NCT03221647 | Completed | INF-α Innate Immune Response to Gliadin | January 10, 2013 | July 1, 2017 | |
| NCT03271138 | Completed | Phase 2 | Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms | July 21, 2017 | December 7, 2017 |
| NCT03288831 | Completed | N/A | Changes in Intestinal Permeability 4 Hours After Gluten Challenge | October 10, 2017 | October 30, 2018 |
| NCT03320811 | Completed | Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited | January 1, 2015 | January 1, 2016 | |
| NCT03321214 | Completed | N/A | Gluten Sensor Device to Promote Gluten Free Diet Adherence and Quality of Life in Patients With Celiac Disease | January 2, 2018 | October 31, 2018 |
| NCT05186038 | Completed | Mass Screening for the Early Detection of Patients With Celiac Disease. | December 18, 2021 | December 31, 2022 | |
| NCT05172895 | Completed | Characteristics of Anemia in Celiac Disease | January 1, 2001 | July 31, 2021 | |
| NCT03364556 | Completed | Nutritional Intake and Bone Health in Celiac Disease | June 2016 | November 2017 | |
| NCT03380988 | Completed | N/A | Fiber-enriched Buckwheat Pasta and Glucose Variability in Patients With Type 1 Diabetes and Celiac Disease | November 2015 | February 2017 |
| NCT03409796 | Completed | N/A | Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge | April 24, 2018 | May 2, 2019 |
| NCT03483805 | Completed | N/A | Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients | December 21, 2016 | January 12, 2018 |
| NCT03486990 | Completed | Phase 1 | Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease | January 23, 2018 | July 22, 2019 |
| NCT03520244 | Completed | N/A | A 12-week Exercise Program for Adults With Celiac Disease | November 15, 2016 | March 30, 2018 |
| NCT03521180 | Completed | A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease | May 11, 2018 | July 18, 2019 | |
| NCT03543540 | Completed | Phase 1 | Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease | May 1, 2018 | September 10, 2018 |
| NCT05052164 | Completed | N/A | Improvement Of Physical And Physiological Parameters In Menopausal Or Post-Menopausal Celiac Women | September 1, 2018 | September 1, 2021 |
| NCT03585478 | Completed | Phase 2 | Latiglutenase as a Treatment for Celiac Disease | March 1, 2019 | January 22, 2021 |
| NCT03707730 | Completed | Phase 2 | A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease | October 29, 2019 | December 31, 2023 |
| NCT04867863 | Completed | SCREENING OF CELIAC DISEASE IN SCHOLAR CHILDREN IN ITALY | May 2015 | June 2018 | |
| NCT03738475 | Completed | Phase 2 | Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease | November 11, 2018 | July 22, 2019 |
| NCT04788797 | Completed | Phase 4 | AN-PEP on Gluten Exposure in Celiacs | March 17, 2021 | July 31, 2022 |
| NCT03775499 | Completed | N/A | Probiotic BL NCC 2705 and Gluten Sensitivity | October 9, 2018 | December 15, 2020 |
| NCT03136731 | Enrolling by invitation | Evidence-based Screening Strategies for Celiac Disease | November 29, 2017 | December 31, 2032 | |
| NCT05740306 | Enrolling by invitation | Irritable Bowel Syndrome Overlaping Celiac Disease | January 22, 2023 | December 31, 2023 | |
| NCT05204446 | Enrolling by invitation | N/A | Behavioral Intervention for Celiac Disease | June 7, 2022 | October 1, 2026 |
| NCT04677699 | Enrolling by invitation | Combined Antibody Screening for Celiac and Diabetes Evaluation | December 2020 | June 2026 | |
| NCT05084937 | Enrolling by invitation | N/A | Celiac Disease in Childhood-Adulthood Transition | November 1, 2021 | December 2026 |
| NCT02202681 | Enrolling by invitation | N/A | Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule | September 16, 2013 | July 2028 |
| NCT05114278 | Not yet recruiting | Phase 4 | Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) | February 15, 2022 | April 15, 2026 |
| NCT06300164 | Not yet recruiting | N/A | The Effect of Unripe Carob Fruit in Celiac Patients | April 1, 2024 | July 1, 2024 |
| NCT06324604 | Not yet recruiting | Phase 1 | Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients | June 2024 | December 2025 |
| NCT06310291 | Not yet recruiting | Early Phase 1 | VTP-1000 in Adults With Celiac Disease | April 2024 | August 2025 |
| NCT06164548 | Not yet recruiting | Celiac Disease Among Egyptian Children With Unexplained Short Stature | January 15, 2024 | March 31, 2025 | |
| NCT06059716 | Not yet recruiting | N/A | Gluten Technology and Education for Celiac Health | July 1, 2024 | August 31, 2028 |
| NCT06283264 | Not yet recruiting | Assessment of Coeliac Disease in Patients With Type 2 Diabetes | March 15, 2024 | December 30, 2026 | |
| NCT05660109 | Recruiting | Phase 2 | A Study to Assess the Safety of TPM502 in Adults With Celiac Disease | December 12, 2022 | May 30, 2024 |
| NCT02061306 | Recruiting | Celiac Disease Genomic Environmental Microbiome and Metabolomic Study | March 2014 | December 2024 | |
| NCT02464150 | Recruiting | N/A | Gluten Challenge in Celiac Disease | April 1, 2017 | August 2028 |
| NCT04014413 | Recruiting | N/A | Safety and Efficacy of Fecal Microbiota Transplantation | July 15, 2019 | October 31, 2030 |
| NCT04280510 | Recruiting | Pathogenic Study of Adult Immune Enteropathies | February 27, 2020 | February 27, 2028 | |
| NCT04477928 | Recruiting | General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery | July 17, 2020 | March 2031 | |
| NCT04530123 | Recruiting | Phase 2 | Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet | June 23, 2022 | October 30, 2025 |
| NCT04614571 | Recruiting | N/A | T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge | November 2, 2020 | September 30, 2024 |
| NCT04655495 | Recruiting | N/A | Impact of a Low-FODMAP Gluten-free Diet on Gut Microbiota and Circulating miRNAs in Celiac Disease Patients | February 6, 2022 | January 9, 2023 |
| NCT05209568 | Recruiting | N/A | Immune Responses to Gluten | January 15, 2023 | September 30, 2029 |
| NCT05555446 | Recruiting | Early Phase 1 | Bovine Colostrum to Prevent Absorption of Gluten | September 22, 2022 | January 1, 2024 |
| NCT05574010 | Recruiting | Phase 1/Phase 2 | A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) | November 15, 2022 | December 31, 2025 |
| NCT05576038 | Recruiting | N/A | Tryptophan for Impaired AhR Signaling in Celiac Disease | December 1, 2022 | June 1, 2025 |
| NCT05581628 | Recruiting | FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE | September 28, 2022 | December 28, 2022 | |
| NCT05597904 | Recruiting | Background of Different Phenotypes of Coeliac Disease | November 8, 2022 | December 31, 2030 | |
| NCT05633706 | Recruiting | Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis | January 9, 2023 | January 1, 2025 | |
| NCT05635266 | Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | October 26, 2021 | October 2025 | |
| NCT05636293 | Recruiting | Phase 2 | Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission | March 1, 2023 | August 1, 2025 |
| NCT05646823 | Recruiting | Phase 2 | Probiotic Blend for Celiac Disease | November 17, 2022 | April 17, 2023 |
| NCT05680012 | Recruiting | N/A | Tissue Destruction and Healing in Celiac Disease | July 14, 2023 | June 30, 2027 |
| NCT05715970 | Recruiting | N/A | ICT Tools for the Diagnosis of Autoimmune Diseases | June 1, 2023 | December 31, 2024 |
| NCT05782257 | Recruiting | N/A | Zinc Deficiency Treatment in Celiac Disease: Supplementation Versus Diet | December 8, 2022 | September 1, 2024 |
| NCT05803408 | Recruiting | N/A | RCT: Effect of Late vs Early Introduction of Gluten-free Oats on Patients With Newly Diagnosed Celiac Disease. | June 1, 2023 | May 2025 |
| NCT05825976 | Recruiting | N/A | Omega-3 Fatty Acid Supplementation and Tear Film Quality in Celiac Patients | March 25, 2023 | August 1, 2023 |
| NCT05894746 | Recruiting | N/A | Gfree - For Improved Blood Sugar and Reduced Inflammation. | May 4, 2023 | December 1, 2030 |
| NCT05904301 | Recruiting | Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases | June 21, 2023 | June 30, 2028 | |
| NCT05983978 | Recruiting | No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays | January 2, 2023 | December 31, 2024 | |
| NCT06001177 | Recruiting | Phase 2 | A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease | December 13, 2023 | June 2025 |
| NCT06007898 | Recruiting | N/A | Supporting Children and Young People to Live Well With Coeliac Disease | May 2, 2024 | September 2024 |
| NCT06072287 | Recruiting | The Living With a Long-Term Condition Study | June 28, 2023 | January 10, 2024 | |
| NCT06151782 | Recruiting | N/A | Immunosafe-CeD: Are Partially Hydrolysed Gluten Hamrful to Celiac Disease Patients? | December 1, 2023 | December 31, 2026 |
| NCT06152289 | Recruiting | Development of New Diagnostic Tools in Capsule Endoscopy | February 10, 2023 | February 2028 | |
| NCT06178107 | Recruiting | N/A | Efficacy of Cholesterol-lowering L. Plantarum on Cardiometabolic Health Biomarkers in Coeliac Disease Patients | April 12, 2022 | December 21, 2025 |
| NCT05119322 | Suspended | N/A | Use of a Home Test for Gluten Detection in Urine and Its Effect on Gluten-free Diet Adherence | March 23, 2021 | December 31, 2027 |
| NCT04306939 | Suspended | Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study | November 1, 2014 | December 1, 2025 | |
| NCT03462979 | Suspended | N/A | Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease | April 15, 2018 | December 31, 2023 |
| NCT00819819 | Terminated | N/A | Infant Nutrition and Risk of Celiac Disease | April 2008 | July 2013 |
| NCT00250146 | Terminated | N/A | Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease | February 2001 | March 2005 |
| NCT02475369 | Terminated | Phase 4 | Pancreatic Enzyme Supplementation for Celiac Disease | May 2015 | December 2019 |
| NCT04839575 | Terminated | Phase 2 | Study of Latiglutenase in T1D/CD Patients | April 6, 2021 | December 19, 2022 |
| NCT01506349 | Terminated | N/A | Assessing Neurocognitive Effects of Gluten Exposure | June 2015 | March 2018 |
| NCT02036944 | Terminated | Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting | March 2014 | January 2015 | |
| NCT03569007 | Terminated | Phase 3 | Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms | May 29, 2019 | July 21, 2022 |
| NCT00739128 | Terminated | N/A | Response to Hepatitis B Vaccine in Celiac Disease Patients | February 2009 | March 2011 |
| NCT02929316 | Terminated | Phase 2 | Vedolizumab Induction May Prevent Celiac Enteritis | June 25, 2018 | October 5, 2018 |
| NCT01902368 | Terminated | N/A | Celiac Disease Screening | September 2013 | August 2014 |
| NCT01642862 | Terminated | Phase 1 | Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration | July 2012 | February 2014 |
| NCT03866538 | Terminated | Phase 4 | Budesonide in Patients With Immune Mediated Enteropathies | September 10, 2019 | October 19, 2021 |
| NCT03168490 | Terminated | N/A | In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease | February 1, 2016 | September 28, 2021 |
| NCT03644069 | Unknown status | Phase 2 | A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) | August 6, 2018 | September 2019 |
| NCT05049876 | Unknown status | Prevalence of Renal Disease in Children With Celiac Disease | October 1, 2021 | October 1, 2022 | |
| NCT05066191 | Unknown status | Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Diet | February 1, 2019 | March 31, 2022 | |
| NCT05094232 | Unknown status | Coeliac Disease in Spain: Determination of Disease Prevalence and Risk Factors | November 1, 2020 | December 31, 2021 | |
| NCT05103150 | Unknown status | Virtual Chromoendoscopy With Magnification in Coeliac Disease. | October 1, 2021 | January 1, 2023 | |
| NCT03434639 | Unknown status | Fluorescence Spectroscopy for Gut Permeability Assessment | March 29, 2019 | September 30, 2021 | |
| NCT02126033 | Unknown status | N/A | Telomeres Parameters in Celiac Disease | ||
| NCT02949765 | Unknown status | N/A | Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease | December 2015 | September 2017 |
| NCT02946827 | Unknown status | N/A | A Low FODMAPs Diet in Celiac Patients With Persistent Gastrointestinal Symptoms | January 2016 | January 2017 |
| NCT02916654 | Unknown status | N/A | Sucrosomial Iron in Patients With Celiac Disease and IDA | April 2015 | December 2017 |
| NCT02806206 | Unknown status | Phase 4 | Prucalopride Prior to Small Bowel Capsule Endoscopy | July 2016 | May 2017 |
| NCT00617838 | Unknown status | N/A | Celiac Disease Prevention | October 2007 | December 2014 |
| NCT01975155 | Unknown status | Dietary Assessment and Mycotoxin Exposure in Celiac Disease | June 2013 | July 2016 | |
| NCT01917630 | Unknown status | Phase 2 | Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients | August 2013 | June 2015 |
| NCT02472119 | Unknown status | Phase 2 | Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment. | June 2015 | August 2015 |
| NCT04160767 | Unknown status | Phase 4 | Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients | January 30, 2019 | July 2021 |
| NCT01159457 | Unknown status | N/A | Comparison of Engerix B Vaccine Versus Sci-B-Vac Vaccine in Celiac Patients | April 2011 | January 2013 |
| NCT04148235 | Unknown status | A Pilot Study to Explore the Role of Gut Flora in Celiac Disease | March 2, 2020 | July 2023 | |
| NCT02325232 | Unknown status | N/A | Enteroscopy for Early Diagnosis of Tumors in Celiac Disease | February 2012 | November 2017 |
| NCT03763487 | Unknown status | N/A | The Aim of This Project is to Verify Whether a Depletion of B Cell Memory Subpopulation ("Marginal-zone-like") CD19 + IgD + CD27 + and CD19 + IgM + CD27 + is a Useful Indicator of Hyposplenism in Patients With Celiac Disease | June 1, 2018 | December 31, 2018 |
| NCT04789993 | Unknown status | Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up | March 15, 2021 | April 30, 2021 | |
| NCT04806737 | Unknown status | Phase 1/Phase 2 | Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease | April 16, 2021 | August 15, 2022 |
| NCT03329534 | Unknown status | N/A | Gluten Related Disorders in Barrett's Esophagus | April 1, 2018 | December 30, 2018 |
| NCT03095573 | Unknown status | N/A | Comparison Between Axial- and Lateral-viewing Capsule Endoscopy in Celiac Disease | March 1, 2017 | February 28, 2019 |
| NCT05135923 | Unknown status | N/A | Glutenfree, Gut Microbiota and Metabolic Regulation | September 1, 2021 | May 1, 2022 |
| NCT03351972 | Unknown status | Phase 4 | Differences in Preparation for Small Bowel Capsule Endoscopy | November 23, 2017 | December 1, 2021 |
| NCT03731806 | Withdrawn | Capsule Endoscopy in Newly Diagnosed Patients of Celiac Disease | April 2019 | April 2020 | |
| NCT04704843 | Withdrawn | Phase 1 | A Study of Guselkumab in Adult Participants With Celiac Disease | June 17, 2021 | September 13, 2021 |
- Disase is a (Disease Ontology)
- DOID:0060031
- Cross Reference ID (Disease Ontology)
- EFO:0001060
- Cross Reference ID (Disease Ontology)
- GARD:11998
- Cross Reference ID (Disease Ontology)
- ICD10CM:K90.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:579.0
- Cross Reference ID (Disease Ontology)
- MESH:D002446
- Cross Reference ID (Disease Ontology)
- MIM:607202
- Cross Reference ID (Disease Ontology)
- MIM:609754
- Cross Reference ID (Disease Ontology)
- MIM:611598
- Cross Reference ID (Disease Ontology)
- MIM:612005
- Cross Reference ID (Disease Ontology)
- MIM:612006
- Cross Reference ID (Disease Ontology)
- MIM:612007
- Cross Reference ID (Disease Ontology)
- MIM:612008
- Cross Reference ID (Disease Ontology)
- MIM:612009
- Cross Reference ID (Disease Ontology)
- MIM:612011
- Cross Reference ID (Disease Ontology)
- NCI:C26714
- Cross Reference ID (Disease Ontology)
- ORDO:555
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:197477005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0007570
- Exact Synonym (Disease Ontology)
- celiac sprue
- Exact Synonym (Disease Ontology)
- coeliac disease
- Exact Synonym (Disease Ontology)
- idiopathic steatorrhea
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002608
- OMIM Phenotype Series Number (OMIM)
- PS212750
- MeSH unique ID (MeSH (Medical Subject Headings))
- D002446